Medical Articles 5/29

Posted by rob on May 30, 2007 under Uncategorized | Be the First to Comment

Long-Term
Outcome of Unrelated Donor Transplantation for AML Using Myeloablative
Conditioning Incorporating Pretransplant Alemtuzumab.

Impact of Cytogenetics on Outcome of De Novo and Therapy-Related AML and MDS after Allogeneic Transplantation.
First
and second line imatinib treatment in chronic myelogenous leukemia
patients expressing rare e1a2 or e19a2 BCR-ABL transcripts.

Familial adenomatous polyposis complicated by chronic myelogenous leukemia: response to imatinib mesylate.

Memorial Day

Posted by rob on May 28, 2007 under Uncategorized | Be the First to Comment

From  tinymercury

 

Medical Articles 5/26

Posted by rob on May 27, 2007 under Uncategorized | Be the First to Comment

STAT3 and PKC Differentially Regulate Telomerase Activity During Megakaryocytic Differentiation of K562 Cells.

Treatment
Interruptions and Non-Adherence with Imatinib and Associated Healthcare
Costs: A Retrospective Analysis among Managed Care Patients with
Chronic Myelogenous Leukaemia.
Potential of gene expression profiling in the management of childhood acute lymphoblastic leukemia.

Composite Nanoparticles Based on Hyaluronic Acid Chemically Cross-Linked with alpha,beta-Polyaspartylhydrazide.

Old Lighthouse, Isle Of Wright

Posted by rob on May 26, 2007 under Uncategorized | Be the First to Comment


From s0ulsurfing

Medical Articles 5/25

Posted by rob on May 25, 2007 under Uncategorized | Be the First to Comment

Cigarette smoking, cytogenetic abnormalities, and acute myelogenous leukemia.

Effect
of 15-lipoxygenase metabolites, 15-(S)-HPETE and 15-(S)-HETE on chronic
myelogenous leukemia cell line K-562: Reactive oxygen species (ROS)
mediate caspase-dependent apoptosis.

c-Abl Tyrosine Kinase and Inhibition by the Cancer Drug Imatinib (Gleevec/STI-571).

Medical Articles 5/20

Posted by rob on May 21, 2007 under Uncategorized | Be the First to Comment

Honokiol Induces a Necrotic Cell Death through the Mitochondrial Permeability Transition Pore.

Monitoring Chronic Myelogenous Leukemia in the Age of Tyrosine Kinase Inhibitors.

Chronic myelogenous leukemia.

Medical Articles 5/18

Posted by rob on May 18, 2007 under Uncategorized | Be the First to Comment

Normal
hematopoietic function and multiple bone marrow clonal abnormalities in
a patient with acute myeloid leukemia after two mismatched stem-cell
transplants with graft failure and autologous reconstitution.

Absence of nucleophosmin 1 (NPM1) gene mutations in common solid cancers.

Medical Articles 5/16

Posted by rob on May 16, 2007 under Uncategorized | Be the First to Comment

[The standard treatments for patients with hematological malignancies in Japan.]

Modulating Autophagy for Therapeutic Benefit.

Digoxin-Like Immunoreactive Factors Induce Apoptosis in Human Acute T-Cell Lymphoblastic Leukemia.

Medical Articles 5/12

Posted by rob on May 12, 2007 under Uncategorized | Be the First to Comment

[Clinical Study on Prognosis of Acute Leukemia Subtypes Ly + AML and My + ALL.]

[Detection of p16 Gene Methylation Status in Adult Patients with Acute Leukemia by Using n-MSP.]
[Construction of 293pT2-P210 Cell Line Enables Expression of bcr/abl to be Regulated by Tet-off Inducing-Expression-System.]
Impact
of natural killer cell dose and donor killer-cell immunoglobulin-like
receptor (KIR) genotype on outcome following human leucocyte
antigen-identical haematopoietic stem cell transplantation.
Basophilic leukemia in recurrent chronic myelogenous leukemia blast phase.
Generalized intramuscular granulocytic sarcoma mimicking polymyositis.

Effects
of Various Methoxyflavones on Vincristine Uptake and Multidrug
Resistance to Vincristine in P-gp-Overexpressing K562/ADM Cells.

Cell Genesys Starts More Trials for Immunotherapy

Posted by rob on May 11, 2007 under Uncategorized | Be the First to Comment

Cell Genesys have started three new clinical
trials for GVAX immunotherapy for leukemia, following encouraging
results in a phase II study.

The trials are now under way in
collaboration with the Johns Hopkins Sidney Kimmel Cancer Center in
patients with chronic myelogenous leukemia (CML). The studies include a
new phase II trial, an extension of the original phase II trial, and a
new phase I trial.

Cell Genesys Starts More Trials for Immunotherapy

Medical Articles 5/11

Posted by rob on under Uncategorized | Be the First to Comment

Chronic myelogenous leukemia: ESMO Clinical Recommendations for diagnosis, treatment and follow-up.

[Experimental advance of targeted medicines for chronic myeloid leukemia - review.]

[Relationship Between Thymus Output Function in CML Patients and Their bcr-abl mRNA Levels.]

Medical Articles 5/10

Posted by rob on May 10, 2007 under Uncategorized | Be the First to Comment

[Organoarsenicals
derived from 2-phenyl-[1,3,2]dithiarsolan-4-yl)-methanol (AsIII) with
antileukaemic properties: from trypanosomicides to anticancer drugs.]

Acute myelogenous leukemia following irinotecan-based chemotherapy for adenocarcinoma of the small intestine.
Paradoxical
proliferative potential of iron (II) sulphate on cancer cells after the
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS) assay.

Diffuse alveolar damage and hemorrhage in acute myelogenous leukemia treated with corticosteroids.

Medical Articles 5/9

Posted by rob on May 9, 2007 under Uncategorized | Be the First to Comment

Laparoscopic appendectomy in a patient with acute myelogenous leukemia with neutropenia.

Studies in target-based treatment.
Dormant
Tumor Cells Develop Cross-Resistance to Apoptosis Induced by CTLs or
Imatinib Mesylate via Methylation of Suppressor of Cytokine Signaling 1.
The
akt/mammalian target of rapamycin signal transduction pathway is
activated in high-risk myelodysplastic syndromes and influences cell
survival and proliferation.

The
Novel Triterpenoid C-28 Methyl Ester of 2-Cyano-3, 12-Dioxoolen-1,
9-Dien-28-Oic Acid Inhibits Metastatic Murine Breast Tumor Growth
through Inactivation of STAT3 Signaling.

Medical Articles 5/4

Posted by rob on May 4, 2007 under Uncategorized | Be the First to Comment

High
levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP
E2-dependent suppression of C/EBP{alpha}-driven Myeloid Differentiation.

[New horizon of chronic myelogenous leukemia]
[The development of new treatments of acute myelogenous leukemia]
[Treatment of chronic myelogenous leukemia with imatinib: current and future therapeutic strategies]

[New horizon of chronic myelogenous leukemia]

Medical Articles 5/2

Posted by rob on May 3, 2007 under Uncategorized | Be the First to Comment

Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age.

Parapharyngeal abscess by Aspergillus flavus in a neutropenic patient with myelogenous leukaemia.
Chronic myelogenous leukemia progenitors display a genetically unstable personality.

Fludarabine
and busulfan as a myeloablative conditioning regimen for allogeneic
stem cell transplantation in high- and standard-risk leukemic patients.

home top